We are live on ! Find out more
RGEN icon

Repligen

303 hedge funds and large institutions have $3.45B invested in Repligen in 2019 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 114 increasing their positions, 94 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 28

21% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 94

12% more funds holding

Funds holding: 270303 (+33)

10% less call options, than puts

Call options by funds: $22.2M | Put options by funds: $24.5M

6.55% less ownership

Funds ownership: 93.86%87.31% (-6.5%)

11% less capital invested

Capital invested by funds: $3.87B → $3.45B (-$421M)

88% less funds holding in top 10

Funds holding in top 10: 81 (-7)

Holders
303
Holders Change
+33
Holders Change %
+12.22%
% of All Funds
6.64%
Holding in Top 10
1
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-87.5%
% of All Funds
0.02%
New
61
Increased
114
Reduced
94
Closed
28
Calls
$22.2M
Puts
$24.5M
Net Calls
-$2.36M
Net Calls Change
-$17.8M
Name Holding Trade Value Shares
Change
Change in
Stake
DLCIG
126
D.L. Carlson Investment Group
New Hampshire
$2.1M -$50.3K -575 -2%
OPERF
127
Oregon Public Employees Retirement Fund
Oregon
$2.07M +$1.01M +11,567 +75%
Los Angeles Capital Management
128
Los Angeles Capital Management
California
$2.06M +$978K +11,180 +71%
Millennium Management
129
Millennium Management
New York
$1.97M +$929K +10,617 +70%
DIA
130
Dana Investment Advisors
Wisconsin
$1.92M -$405K -4,626 -16%
MSA
131
Mason Street Advisors
Wisconsin
$1.86M +$900K +10,292 +73%
State Board of Administration of Florida Retirement System
132
State Board of Administration of Florida Retirement System
Florida
$1.86M
IBT
133
International Biotechnology Trust
United Kingdom
$1.84M
WAM
134
Weiss Asset Management
Massachusetts
$1.84M +$2.1M +24,000 New
William Blair & Company
135
William Blair & Company
Illinois
$1.83M -$423K -4,840 -17%
LCM
136
Laurion Capital Management
New York
$1.79M +$149K +1,709 +8%
AAMU
137
Amundi Asset Management US
Massachusetts
$1.74M -$2.12M -24,200 -52%
Canada Life
138
Canada Life
Manitoba, Canada
$1.71M -$2.97M -33,952 -60%
Jane Street
139
Jane Street
New York
$1.7M +$1.94M +22,177 New
Bank of Montreal
140
Bank of Montreal
Ontario, Canada
$1.63M +$1.07M +12,252 +136%
VRS
141
Virginia Retirement Systems
Virginia
$1.62M -$236K -2,700 -11%
BA
142
Boston Advisors
Massachusetts
$1.6M +$445K +5,087 +32%
CSS
143
Cubist Systematic Strategies
Connecticut
$1.59M +$62.4K +713 +4%
AG
144
Algert Global
California
$1.58M -$123K -1,402 -6%
Envestnet Asset Management
145
Envestnet Asset Management
Illinois
$1.56M -$21.4K -245 -1%
AG
146
Advisor Group
Arizona
$1.56M -$238K -2,720 -12%
SEI Investments
147
SEI Investments
Pennsylvania
$1.54M +$9.97K +114 +0.6%
SO
148
STRS Ohio
Ohio
$1.53M +$78.7K +900 +5%
EI
149
EAM Investors
California
$1.36M -$542K -6,192 -26%
AIP
150
Ameritas Investment Partners
Nebraska
$1.34M +$1.17M +13,362 +330%

RGEN Hedge Fund Activity: Q3 2019 in Review

303 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q3 2019, worth a combined $3.45B — down 11% from $3.87B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new RGEN positions and 28 closed out — a net gain of 33 holders — while 114 added to existing stakes and 94 trimmed.

The largest buyer was State Street, adding an estimated $44.8M. The largest seller was BlackRock, cutting an estimated $62.1M.

  • 303 institutional investors held Repligen (RGEN) as of Q3 2019, up from 270 in Q2 2019.
  • Funds reported $3.45B of Repligen stock for Q3 2019, down 11% quarter-over-quarter.
  • 61 funds opened new Repligen positions in Q3 2019 and 28 closed out, a net change of +33 holders.
  • The largest Repligen buyer in Q3 2019 was State Street, an estimated $44.8M added.
  • The largest Repligen seller in Q3 2019 was BlackRock, an estimated $62.1M sold.

Based on aggregated 13F filings for Q3 2019.